Literature DB >> 26738874

A medulloblastoma showing an unusually long doubling time: reflection of its singular nature.

Omer Doron1, Jacob Zauberman2, Ze'ev Feldman2.   

Abstract

CASE DESCRIPTION: In this paper, we present a case of a 4-year-old male diagnosed with a desmoplastic, SHH-type medulloblastoma. Retrospectively, we discovered that the patient underwent an MRI scan at 21 months for reasons unrelated, revealing a T1-enhanced lesion at the vermis, later recognized as the source of the tumor. This unique case provides us with a glimpse into the natural history of this tumor. Our ability to measure tumor volume at two defined time points, 31 months apart, enabled us to deduce the tumor's doubling time. This is defined as the time of one cell cycle divided by the amount of cycling cells, multiplied by cell loss factor. Potential doubling time (Tpot) and actual doubling time (Td), calculated using the Gompertzian model, are the most clinically relevant with regard to a tumor's response to radiotherapy. Here, we show an actual doubling-time (Td) of 78 days, and an extrapolated tumor diameter at the time of birth of 0.25 mm. CLINICAL RELEVANCE: These results both support the medulloblastoma's embryonic origin, and indicating a threefold longer actual doubling time when compared to previous studies. Taking into account the reported range of medulloblastoma potential doubling time, we deduced a cell loss factor of between 48.9 and 95.5 %. These percentages fall in line with other malignant tumors. Although limited due to the obvious reliance on only two points in time and using the Gompertzian model to complete the remainder, to the best of our knowledge, this is the longest follow-up period reported for medulloblastoma. We have described how a unique turn of events enabled us to get a glimpse into the in situ development of a medulloblastoma over a 31-month period. Regarded sometimes as an idiosyncratic tumor comprised of an array of molecular changes, the complexity of medulloblastoma is displayed here, by revealing for the first time an actual doubling time three- to fourfold the previously known length.

Entities:  

Keywords:  Doubling time; Gompertzian model; Medulloblastoma; Pediatric neurosurgery

Mesh:

Year:  2016        PMID: 26738874     DOI: 10.1007/s00381-015-2997-7

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  15 in total

1.  A biomathematical approach to clinical tumor growth.

Authors:  M SCHWARTZ
Journal:  Cancer       Date:  1961 Nov-Dec       Impact factor: 6.860

2.  Cell kinetic analysis of human brain tumors by in situ double labelling with bromodeoxyuridine and iododeoxyuridine.

Authors:  T Hoshino; S Ito; A Asai; M Shibuya; M D Prados; B A Dodson; R L Davis; C B Wilson
Journal:  Int J Cancer       Date:  1992-01-02       Impact factor: 7.396

3.  A novel zinc finger protein, zic, is involved in neurogenesis, especially in the cell lineage of cerebellar granule cells.

Authors:  J Aruga; N Yokota; M Hashimoto; T Furuichi; M Fukuda; K Mikoshiba
Journal:  J Neurochem       Date:  1994-11       Impact factor: 5.372

Review 4.  Classifying the medulloblastoma: insights from morphology and molecular genetics.

Authors:  D Ellison
Journal:  Neuropathol Appl Neurobiol       Date:  2002-08       Impact factor: 8.090

5.  Congenital medulloblastoma: an inquiry into origins.

Authors:  A L Amacher; Q U Torres; S Rittenhouse
Journal:  Childs Nerv Syst       Date:  1986       Impact factor: 1.475

6.  MR imaging features of medulloblastomas.

Authors:  S P Meyers; S S Kemp; R W Tarr
Journal:  AJR Am J Roentgenol       Date:  1992-04       Impact factor: 3.959

7.  Estimation of rate of growth of malignant brain tumors by computed tomography scanning.

Authors:  T Yamashita; T Kuwabara
Journal:  Surg Neurol       Date:  1983-12

Review 8.  Medulloblastomas and related primitive neuroectodermal brain tumors of childhood recapitulate molecular milestones in the maturation of neuroblasts.

Authors:  J Q Trojanowski; T Tohyama; V M Lee
Journal:  Mol Chem Neuropathol       Date:  1992-10

9.  Subtypes of medulloblastoma have distinct developmental origins.

Authors:  Paul Gibson; Yiai Tong; Giles Robinson; Margaret C Thompson; D Spencer Currle; Christopher Eden; Tanya A Kranenburg; Twala Hogg; Helen Poppleton; Julie Martin; David Finkelstein; Stanley Pounds; Aaron Weiss; Zoltan Patay; Matthew Scoggins; Robert Ogg; Yanxin Pei; Zeng-Jie Yang; Sonja Brun; Youngsoo Lee; Frederique Zindy; Janet C Lindsey; Makoto M Taketo; Frederick A Boop; Robert A Sanford; Amar Gajjar; Steven C Clifford; Martine F Roussel; Peter J McKinnon; David H Gutmann; David W Ellison; Robert Wechsler-Reya; Richard J Gilbertson
Journal:  Nature       Date:  2010-12-08       Impact factor: 49.962

10.  Cell cycle times of short-term cultures of brain cancers as predictors of survival.

Authors:  C E Furneaux; E S Marshall; K Yeoh; S J Monteith; P J Mews; C A Sansur; R J Oskouian; K J Sharples; B C Baguley
Journal:  Br J Cancer       Date:  2008-10-14       Impact factor: 7.640

View more
  1 in total

1.  Natural History of Medulloblastoma in a Child with Neurofibromatosis Type I.

Authors:  Mehdi Golpayegani; Farhad Salari; Zohreh Habibi; Mousarreza Anbarlouei; Ali Mahdavi; Farideh Nejat
Journal:  Asian J Neurosurg       Date:  2018 Jul-Sep
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.